Klaus Witthohn

15 papers receiving 385 citations

Peers

Klaus Witthohn
Comparison fields: 5 of 72
  • Biotechnology 117
  • Immunology 187
  • Complementary and alternative medicine 41
  • Toxicology 13
  • Molecular Biology 217
Replace Tae Kwang Ha with:
Tae Kwang Ha South Korea
Felipe V. Pereira Brazil
Diana Bachran Germany
Rakha H. Das India
Stefan Böttger Germany
Huange Zhao China
N.R. Worrell United Kingdom
Cláudia Figueirêdo Lóssio Brazil
M Zamboni Italy
Klaus Witthohn relative to Tae Kwang Ha South Korea Tae Kwang Ha's profile →
Citations per field
00.5×2.9×
Tae Kwang Ha · 1×
Citations per year

Countries citing papers authored by Klaus Witthohn

Since Specialization
Citations

This map shows the geographic impact of Klaus Witthohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Witthohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Witthohn more than expected).

Fields of papers citing papers by Klaus Witthohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Witthohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Witthohn. The network helps show where Klaus Witthohn may publish in the future.

Co-authors

The 25 scholars most cited alongside Klaus Witthohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Klaus Witthohn Line = papers co-authored together Klaus Witthohn links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 199971
2 200061
3 200454
4 201141
5 200340
6 200134
7 200425
8 200321
9 199314
10 200512
11 200311
12 20147
13 20037
14
Binding of recombinant mistletoe lectin (aviscumine) to resected human adenocarcinoma of the lung.
20055
15 20151

About Klaus Witthohn

Klaus Witthohn is a scholar working on Biotechnology, Immunology, Pharmaceutical Science, Plant Science and Complementary and alternative medicine, having authored 15 papers that have together received 404 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (10 papers), Transgenic Plants and Applications (9 papers), Plant Parasitism and Resistance (3 papers), Glycosylation and Glycoproteins Research (3 papers), Drug Solubulity and Delivery Systems (2 papers), Protein purification and stability (2 papers), Microbial Metabolites in Food Biotechnology (1 paper) and Fungal Plant Pathogen Control (1 paper). The work is most often cited by research in Biotechnology (117 citations), Immunology (187 citations), Complementary and alternative medicine (41 citations), Toxicology (13 citations) and Molecular Biology (217 citations). Klaus Witthohn has collaborated with scholars based in Germany, Sweden and Croatia. Frequent co-authors include Martin Langer, Hans Lentzen, Birgit Classen, W. Blaschek, Jürgen Eck, Hartwig Steckel, Holger Zinke, Babette Möckel, U. Neumann and Iris Meisen. Their work appears in journals such as European Journal of Cancer, Electrophoresis, Pharmacology, European Journal of Biochemistry and Journal of Pharmaceutical and Biomedical Analysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026